In a hypertensive adult patient on losartan with well‑controlled blood pressure who has had 2 days of vomiting, dizziness/vertigo, and tinnitus, what are the possible etiologies and recommended next steps in management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differential Diagnosis and Management Approach

In this patient with 2 days of vomiting, dizziness, and tinnitus on losartan with controlled blood pressure, the most critical immediate step is to distinguish between peripheral vestibular disorders (particularly Ménière's disease or vestibular neuritis) and central neurological causes (stroke/TIA), while also considering losartan-related adverse effects.

Key Diagnostic Considerations

Primary Differential Diagnoses

Peripheral Vestibular Disorders:

  • Ménière's disease presents with episodic vertigo lasting 20 minutes to 12 hours, fluctuating hearing loss, tinnitus, and aural fullness—matching this patient's symptom triad 1
  • Vestibular neuritis/labyrinthitis causes acute vertigo with nausea/vomiting but typically lacks tinnitus unless hearing is affected
  • Benign paroxysmal positional vertigo (BPPV) causes brief episodes triggered by head position changes, not sustained 2-day symptoms

Central Neurological Causes:

  • Posterior circulation stroke/TIA must be excluded urgently, particularly given hypertension as a risk factor 2
  • Vertebrobasilar insufficiency can present with vertigo, though typically with additional brainstem signs

Medication-Related:

  • Losartan adverse effects: Dizziness occurs in 3-4% of patients on losartan (vs. 2% on placebo), though typically not with tinnitus 3, 4
  • Orthostatic hypotension from excessive blood pressure lowering, though the patient has "adequate control" 5

Other Considerations:

  • Vestibular migraine can mimic Ménière's disease with vertigo episodes and auditory symptoms 1
  • Spontaneous intracranial hypotension rarely causes this triad with positional worsening 6

Immediate Management Steps

1. Urgent Clinical Assessment (Within Hours)

Verify true vertigo vs. lightheadedness:

  • Confirm rotational spinning sensation (true vertigo suggests vestibular pathology) vs. presyncope/lightheadedness (suggests cardiovascular/orthostatic cause) 1
  • Document if symptoms worsen with head position changes (BPPV) or are constant

Neurological examination to exclude stroke:

  • Test for focal neurological deficits: facial weakness, limb weakness, sensory loss, ataxia, dysarthria
  • Perform HINTS examination (Head Impulse, Nystagmus, Test of Skew) if trained—abnormal findings suggest central cause requiring immediate imaging
  • Check for signs of cerebellar dysfunction (finger-to-nose, heel-to-shin testing)

Orthostatic vital signs:

  • Measure blood pressure and heart rate supine and after 1-3 minutes standing
  • Orthostatic hypotension defined as SBP drop ≥20 mmHg or DBP drop ≥10 mmHg 5
  • Despite controlled baseline BP, assess if losartan is causing excessive lowering with position changes

Otologic examination:

  • Perform otoscopy to exclude middle ear pathology
  • Assess for spontaneous nystagmus (peripheral: horizontal-rotatory, suppressed by visual fixation; central: vertical or direction-changing)
  • Document hearing subjectively; formal audiometry needed if hearing loss suspected

2. Laboratory and Diagnostic Testing

Basic metabolic panel (within 24 hours):

  • Check electrolytes (sodium, potassium), creatinine, and glucose 5
  • Losartan can cause hyponatremia (particularly with vomiting) and electrolyte disturbances that may contribute to symptoms 5
  • Assess for dehydration from 2 days of vomiting

Formal audiometry (within 1 week if hearing symptoms present):

  • Pure tone audiometry to document any sensorineural hearing loss
  • Low-frequency hearing loss suggests Ménière's disease 1, 7
  • If sudden hearing loss confirmed, consider urgent corticosteroid therapy 7

Brain MRI with contrast (urgent if any red flags):

  • Obtain emergently if: focal neurological signs, severe headache, altered mental status, vertical nystagmus, or HINTS examination suggests central cause
  • Obtain non-urgently (within 1-2 weeks) if: recurrent episodes to exclude vestibular schwannoma or other CPA tumors, particularly with unilateral tinnitus and hearing loss 1, 7
  • MRI of internal auditory canals specifically if Ménière's disease suspected to exclude structural lesions

3. Medication Review and Adjustment

Assess losartan contribution:

  • While dizziness is a known losartan side effect (4.1% vs. 2.4% placebo) 3, 4, the combination with tinnitus and 2-day duration makes primary vestibular pathology more likely
  • Do not discontinue losartan immediately unless orthostatic hypotension confirmed or symptoms clearly medication-related
  • If orthostatic hypotension present, consider dose reduction rather than discontinuation 5

Review for interacting medications:

  • Check for NSAIDs, diuretics, or other medications that may interact with losartan or contribute to symptoms 5
  • Assess for any recent medication changes

4. Symptomatic Management

Acute vertigo control:

  • Meclizine 25-50 mg every 6-8 hours or dimenhydrinate 50 mg every 6 hours for acute vestibular symptoms
  • Ondansetron 4-8 mg for nausea/vomiting control
  • Limit vestibular suppressants to 3-5 days to avoid delaying central compensation

Hydration:

  • IV fluids if unable to tolerate oral intake after 2 days of vomiting
  • Correct any electrolyte abnormalities identified

Safety precautions:

  • Fall precautions given dizziness and hypertension (increased stroke risk) 8
  • Avoid driving until symptoms resolve

Specific Management Based on Diagnosis

If Ménière's Disease Confirmed:

  • Low-sodium diet (<1500-2000 mg/day)
  • Consider diuretic therapy (though monitor carefully with losartan)
  • Refer to otolaryngology for specialized management 1

If Vestibular Neuritis/Labyrinthitis:

  • Vestibular rehabilitation therapy after acute phase
  • Corticosteroids may be beneficial if started within 3 days of onset

If Medication-Related:

  • Adjust losartan dose or switch to alternative antihypertensive (e.g., amlodipine, which has lower dizziness rates) 9
  • Ensure adequate hydration and gradual position changes

If Central Cause Identified:

  • Immediate neurology consultation
  • Stroke protocol activation if acute ischemia
  • Optimize vascular risk factor control 2

Critical Red Flags Requiring Emergency Evaluation

  • Sudden severe headache (worst headache of life)
  • Focal neurological deficits (weakness, numbness, speech changes)
  • Altered mental status or confusion
  • Vertical or direction-changing nystagmus
  • Severe uncontrolled hypertension (≥180/120 mmHg) with symptoms suggesting hypertensive emergency 2
  • Complete hearing loss or sudden hearing loss requiring urgent corticosteroid consideration 7

Follow-Up Strategy

If symptoms improve with conservative management:

  • Recheck blood pressure and orthostatic vitals in 1 week
  • Repeat basic metabolic panel in 2-4 weeks if losartan continued 5
  • Audiology referral if tinnitus or hearing symptoms persist
  • ENT referral if recurrent episodes or diagnosis remains unclear

If symptoms persist beyond 5-7 days or worsen:

  • Urgent ENT and/or neurology consultation
  • Consider MRI brain/IAC if not already obtained
  • Reassess medication regimen and consider losartan discontinuation trial

The key pitfall to avoid is attributing all symptoms to losartan without excluding serious vestibular or neurological pathology, particularly given the specific triad of vertigo, vomiting, and tinnitus that strongly suggests primary vestibular disease rather than simple medication side effects.

References

Guideline

clinical practice guideline: ménière's disease.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020

Research

Safety and tolerability of losartan compared with atenolol, felodipine and angiotensin converting enzyme inhibitors.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1995

Guideline

clinical practice guideline: sudden hearing loss (update).

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2019

Related Questions

In a male patient with elevated liver transaminases indicating mild hepatic impairment, how should losartan be started and titrated?
Is one week sufficient to determine whether reducing losartan from 50 mg to 25 mg once daily adequately controls blood pressure, or should I wait longer before reassessing?
Can losartan cause leg pain?
When should I take my 25 mg dose of losartan in relation to the GaviLyte‑G bowel preparation?
In a 31‑year‑old woman with hypertension on losartan (angiotensin II receptor blocker) and amlodipine (calcium channel blocker) who presents with a three‑day fever, severe right‑sided headache radiating to the neck, nocturnal awakening, and a blood pressure of 230/140 mm Hg with tachycardia, what is the appropriate acute management, including blood pressure reduction, infectious work‑up, and empiric therapy?
For a patient with intellectual disability and early dementia, what is the recommended starting dose and which is preferred, donepezil (Aricept) or memantine (Namenda)?
What review of systems should be performed before initiating hormone replacement therapy?
Should the cardiac risks of quetiapine (Seroquel) and trazodone affect the plan to start donepezil, and how closely should cardiac safety be monitored?
A child who missed the 2‑month well‑child visit and was seen at 3 months can be scheduled for the 4‑month well‑child visit in one month?
Which laboratory tests are recommended for evaluating suspected myasthenia gravis?
Is tramadol 50 mg an appropriate dose for a 33-year-old male with a toe fracture?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.